1. [8] Ogawa, S., Watanabe, M., Sakurai, Y., Inutake, Y., Watanabe, S., Tai, X., et al. CD28 signaling in primary CD4+ T cells: identification of both tyrosine phosphorylation-dependent and phosphorylation-independent pathways. Int. Immunol. 25, 671–681 (2013).
2. [9] Higo, K., Ikura, T., Oda, M., Morii, H., Takahashi, J., Abe, R., et al. High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28. PLoS One 8, e74482 (2013).
3. [10] Inaba, S., Numoto, N., Ogawa, S., Morii, H., Ikura, T., Abe, R., et al. Crystal structures and thermodynamic analysis reveal distinct mechanisms of CD28 phosphopeptide binding to the Src homology 2 (SH2) domains of three adaptor proteins. J. Biol. Chem. 292, 1052–1060 (2017).
4. [11] Rahuel, J., Gay, B., Erdmann, D., Strauss, A., Garcia-Echeverría, C., Furet, P., et al. Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat. Struct. Biol. 3, 586–589 (1996).
5. [13] Rahuel, J., García-Echeverría, C., Furet, P., Strauss, A., Caravatti, G., Fretz, H., et al. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. J. Mol. Biol. 279, 1013–1022 (1998).